Latest Breaking News On - Universal cancer peptide - Page 1 : comparemela.com

Enterome to Present Data on EO2401 in Adrenal Tumors at the European Society for Medical Oncology (ESMO) 2023 Congress

Oral Presentation at ESMO will feature updated results from Phase 1/2 SPENCER studyPARIS, Oct. 16, 2023 (GLOBE NEWSWIRE) Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announced that updated data from its Phase 1/2 SPENCER study on EO2401, in combination with nivolumab in patients with adrenal tumors, will be presented in an oral session at the European

France generalGuillaume bayreWeid europeGustave roussy villejuifEric baudinAshleyr robinsonLifesci advisorsEuropean society for medical oncologyHealth scienceHead of external communicationsOral presentationEuropean societyMedical oncologyAssociate professorEndocrine oncology unitGustave roussy

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Saint antoineFrance generalEnterome oncomimicsSylvie berrebi markRomain cohenGuillaume bayreHead of external communicationsProfessor of oncology at sorbonne university parisHealth scienceMinimal residual diseaseAssistant professorSorbonne universityCoordinating investigatorChief executive officerMark swallowTumor associated antigens

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Saint antoineFrance generalSylvie berrebi markRomain cohenEnterome oncomimicsProfessor of oncology at sorbonne university parisHealth scienceMinimal residual diseaseAssistant professorSorbonne universityCoordinating investigatorChief executive officerExternal communicationstelMark swallowTumor associated antigensUniversal cancer peptide

Enterome completes patient enrollment of Phase 2 ROSALIE study evaluating its lead immunotherapy, EO2401, in recurrent glioblastoma

/PRNewswire/ Enterome, a clinical stage company developing first-in-class immunomodulatory drugs based on its gut bacterial Mimicry drug discovery platform,.

United statesFrance generalGuillaume bayreDavid reardonPrnewswire enteromeSylvie berrebi markHead of external communicationsEsmo io annual congressHealth scienceDana farber cancer instituteClinical directorTumor associated antigensUniversal cancer peptideChief executive officerMark swallow

Enterome presents two posters on Phase 2 data of its lead immunotherapy, EO2401, in recurrent glioblastoma (ROSALIE study) at ESMO IO 2022

/PRNewswire/ Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its gut bacterial Mimicry drug.

Baden wübergFrance generalGuillaume bayreSylvie berrebi markWolfgang wickHead of external communicationsOncology congressHealth scienceGerman cancer research centerThursday decemberPoster display sessionTumor associated antigensUniversal cancer peptideMark swallow